Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two laser systems for breaking up kidney stones

Official title: Prospective Single-center Study Comparing Thulium Fiber Laser to Pulsed Thulium:YAG Laser in the Ureteroscopic Treatment of Nephrolithiasis

Run by University of California, San Diego · NCT06721975 · Data updated 2026-11-12

This study is testing whether a new type of laser for breaking up kidney stones works as well and as quickly as a current laser option during a minimally invasive procedure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations1 site (San Diego, California)
StatusRecruiting
StartedAugust 1, 2024
Main results expectedAugust 1, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 9, 2026
Trial IDNCT06721975 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with solitary renal stones measuring 7 to 20 mm who are suitable for flexible ureteroscopy.

Probably not a fit

Patients with concomitant ureteral stones, prior reconstructive procedures, or certain medical conditions such as pregnancy or untreated urinary tract infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the effectiveness of two laser systems, the Thulium Fiber Laser (TFL) and the Thulio Pulsed Thulium:YAG (p-Tm:YAG), in treating kidney stones through ureteroscopy. The study aims to determine if the p-Tm:YAG laser is as effective as TFL in terms of dusting ablation efficiency and speed. Participants will undergo a minimally invasive procedure where the lasers will be used to break up kidney stones, with outcomes measured in a controlled environment. This is the first large-scale study directly comparing these two laser technologies for kidney stone treatment.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients with kidney stones, potentially enhancing the efficiency and effectiveness of laser lithotripsy.

How similar studies have gone: While there have been pilot studies on the p-Tm:YAG laser, this is the first large-scale comparative trial, making it a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Solitary renal stone 7 to 20 mm in size or in the case of multiple stones the conglomerate diameter (additive maximal diameter of all stones on axial imaging of computed tomography) of 7-20 mm is required
* Must be a suitable operative candidate for flexible ureteroscopy per American Urological Association guidelines
* Must be able to give consent
* Bilateral ureteroscopy will be permitted but only the first side (per surgeon discretion) will be included in the study
* Surgeons participating in the study must be urological attending surgeons or fellows with subspecialty training in Endourology

Exclusion Criteria:

* Concomitant stones in the ureter
* Prior ipsilateral upper urinary tract reconstructive procedures or history of ipsilateral ureteral stricture
* Prior radiotherapy to the abdomen or pelvis
* Neurogenic bladder or spinal cord injury
* Pregnancy
* Untreated UTI

Where it's running

  • University of California, San Diego
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.